439 related articles for article (PubMed ID: 30742586)
1. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic strategies for targeting neurodegenerative protein misfolding disorders.
Scannevin RH
Curr Opin Chem Biol; 2018 Jun; 44():66-74. PubMed ID: 29902695
[TBL] [Abstract][Full Text] [Related]
3. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
4. Involvement of molecular chaperone in protein-misfolding brain diseases.
Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acid aptamers for neurodegenerative diseases.
Bouvier-Müller A; Ducongé F
Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
[TBL] [Abstract][Full Text] [Related]
7. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
8. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
9. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
Mulligan VK; Chakrabartty A
Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
[TBL] [Abstract][Full Text] [Related]
10. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
Maiti P; Manna J; Veleri S; Frautschy S
Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
[TBL] [Abstract][Full Text] [Related]
11. Nuclear Ubiquitin-Proteasome Pathways in Proteostasis Maintenance.
Franić D; Zubčić K; Boban M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33406777
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy targeting misfolded proteins in neurodegenerative disease].
Kanemaru K
Brain Nerve; 2013 Apr; 65(4):469-74. PubMed ID: 23568995
[TBL] [Abstract][Full Text] [Related]
13. The disturbance of protein synthesis/degradation homeostasis is a common trait of age-related neurodegenerative disorders.
Di Domenico F; Lanzillotta C
Adv Protein Chem Struct Biol; 2022; 132():49-87. PubMed ID: 36088079
[TBL] [Abstract][Full Text] [Related]
14. Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.
Fatima MT; Islam Z; Ahmad E; Salahuddin P
Curr Protein Pept Sci; 2018; 19(9):858-875. PubMed ID: 28762306
[TBL] [Abstract][Full Text] [Related]
15. Potential Influence of Cyclo(His-Pro) on Proteostasis: Impact on Neurodegenerative Diseases.
Grottelli S; Costanzi E; Peirce MJ; Minelli A; Cellini B; Bellezza I
Curr Protein Pept Sci; 2018; 19(8):805-812. PubMed ID: 29708066
[TBL] [Abstract][Full Text] [Related]
16. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
Bose S; Cho J
Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
[TBL] [Abstract][Full Text] [Related]
17. Quality control of the proteins associated with neurodegenerative diseases.
Gao X; Hu H
Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
[TBL] [Abstract][Full Text] [Related]
18. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.
Thibaudeau TA; Anderson RT; Smith DM
Nat Commun; 2018 Mar; 9(1):1097. PubMed ID: 29545515
[TBL] [Abstract][Full Text] [Related]
19. Protein S-nitrosylation and oxidation contribute to protein misfolding in neurodegeneration.
Nakamura T; Oh CK; Zhang X; Lipton SA
Free Radic Biol Med; 2021 Aug; 172():562-577. PubMed ID: 34224817
[TBL] [Abstract][Full Text] [Related]
20. Pathways of cellular proteostasis in aging and disease.
Klaips CL; Jayaraj GG; Hartl FU
J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]